The findings suggest that MG+/US- NPBC exhibits a favorable prognosis, characterized by a higher prevalence of DCIS, potentially positioning it as an ‘ultra-low risk’ cancer subtype. Here, MGAM is linked to ductal breast carcinoma in situ.